Literature DB >> 12682019

HIV reproducibly establishes a latent infection after acute infection of T cells in vitro.

Albert Jordan1, Dwayne Bisgrove, Eric Verdin.   

Abstract

The presence of latent reservoirs has prevented the eradication of human immunodeficiency virus (HIV) from infected patients successfully treated with anti-retroviral therapy. The mechanism of postintegration latency is poorly understood, partly because of the lack of an in vitro model. We have used an HIV retroviral vector or a full-length HIV genome expressing green fluorescent protein to infect a T lymphocyte cell line in vitro and highly enrich for latently infected cells. HIV latency occurred reproducibly, albeit with low frequency, during an acute infection. Clonal cell lines derived from latent populations showed no detectable basal expression, but could be transcriptionally activated after treatment with phorbol esters or tumor necrosis factor alpha. Direct sequencing of integration sites demonstrated that latent clones frequently contain HIV integrated in or close to alphoid repeat elements in heterochromatin. This is in contrast to a productive infection where integration in or near heterochromatin is disfavored. These observations demonstrate that HIV can reproducibly establish a latent infection as a consequence of integration in or near heterochromatin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12682019      PMCID: PMC154479          DOI: 10.1093/emboj/cdg188

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  33 in total

Review 1.  A survey of the genomic distribution of alpha satellite DNA on all the human chromosomes, and derivation of a new consensus sequence.

Authors:  K H Choo; B Vissel; A Nagy; E Earle; P Kalitsis
Journal:  Nucleic Acids Res       Date:  1991-03-25       Impact factor: 16.971

2.  A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency.

Authors:  S Emiliani; C Van Lint; W Fischle; P Paras; M Ott; J Brady; E Verdin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

3.  A novel PCR technique using Alu-specific primers to identify unknown flanking sequences from the human genome.

Authors:  M Minami; K Poussin; C Bréchot; P Paterlini
Journal:  Genomics       Date:  1995-09-20       Impact factor: 5.736

4.  Latent reservoirs of HIV: obstacles to the eradication of virus.

Authors:  T W Chun; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

Review 5.  HIV integration. Ini1 for integration?

Authors:  M D Miller; F D Bushman
Journal:  Curr Biol       Date:  1995-04-01       Impact factor: 10.834

Review 6.  Position effect variegation in yeast.

Authors:  K D Tartof
Journal:  Bioessays       Date:  1994-10       Impact factor: 4.345

Review 7.  Cytokine modulation of HIV expression.

Authors:  G Poli; A S Fauci
Journal:  Semin Immunol       Date:  1993-06       Impact factor: 11.130

8.  Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5.

Authors:  G V Kalpana; S Marmon; W Wang; G R Crabtree; S P Goff
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

9.  NF-kappa B-dependent and -independent pathways of HIV activation in a chronically infected T cell line.

Authors:  B A Antoni; A B Rabson; A Kinter; M Bodkin; G Poli
Journal:  Virology       Date:  1994-08-01       Impact factor: 3.616

10.  Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation.

Authors:  C Van Lint; S Emiliani; M Ott; E Verdin
Journal:  EMBO J       Date:  1996-03-01       Impact factor: 11.598

View more
  465 in total

1.  Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes.

Authors:  Yefei Han; Kara Lassen; Daphne Monie; Ahmad R Sedaghat; Shino Shimoji; Xiao Liu; Theodore C Pierson; Joseph B Margolick; Robert F Siliciano; Janet D Siliciano
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

Review 2.  HIV latency.

Authors:  Robert F Siliciano; Warner C Greene
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

3.  Transcriptional bursting from the HIV-1 promoter is a significant source of stochastic noise in HIV-1 gene expression.

Authors:  Abhyudai Singh; Brandon Razooky; Chris D Cox; Michael L Simpson; Leor S Weinberger
Journal:  Biophys J       Date:  2010-04-21       Impact factor: 4.033

4.  Combinatorial latency reactivation for HIV-1 subtypes and variants.

Authors:  John C Burnett; Kwang-Il Lim; Arash Calafi; John J Rossi; David V Schaffer; Adam P Arkin
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

Review 5.  Studies of HIV-1 latency in an ex vivo model that uses primary central memory T cells.

Authors:  Alberto Bosque; Vicente Planelles
Journal:  Methods       Date:  2010-10-21       Impact factor: 3.608

6.  Histonedeacetylase inhibitor Oxamflatin increase HIV-1 transcription by inducing histone modification in latently infected cells.

Authors:  Hao Yin; Yuhao Zhang; Xin Zhou; Huanzhang Zhu
Journal:  Mol Biol Rep       Date:  2010-12-23       Impact factor: 2.316

7.  CRISPR-mediated Activation of Latent HIV-1 Expression.

Authors:  Prajit Limsirichai; Thomas Gaj; David V Schaffer
Journal:  Mol Ther       Date:  2015-11-26       Impact factor: 11.454

Review 8.  Molecular mechanisms of HIV latency.

Authors:  Daniele C Cary; Koh Fujinaga; B Matija Peterlin
Journal:  J Clin Invest       Date:  2016-01-05       Impact factor: 14.808

9.  Specific Reactivation of Latent HIV-1 by dCas9-SunTag-VP64-mediated Guide RNA Targeting the HIV-1 Promoter.

Authors:  Haiyan Ji; Zhengtao Jiang; Panpan Lu; Li Ma; Chuan Li; Hanyu Pan; Zheng Fu; Xiying Qu; Pengfei Wang; Junxiao Deng; Xinyi Yang; Jianhua Wang; Huanzhang Zhu
Journal:  Mol Ther       Date:  2016-01-18       Impact factor: 11.454

10.  Primary cell model for activation-inducible human immunodeficiency virus.

Authors:  Bryan Burke; Helen J Brown; Matthew D Marsden; Gregory Bristol; Dimitrios N Vatakis; Jerome A Zack
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.